Hungary imposes windfall tax on drug producers to plug budget gap
2022-12-24
BUDAPEST, Dec 24 (Reuters) - Hungary's government has imposed a windfall tax on drug producers based on net revenues generated in 2022 and 2023, as it tries to plug holes in the state budget.
According to a government decree late on Friday, the rate increases progressively, and will be 8% on net revenues exceeding 150 billion forints ($398 million).
Companies must pay the new tax for both 2022 and 2023 next year, as the government tries to narrow the deficit, which is expected to hit 6.1% of economic output this year.
Nationalist Prime Minister Viktor Orban earlier this year imposed big windfall taxes on a range of sectors including banks, insurers, energy and airlines.
That rattled investors and recalled memories of similar taxes that the populist Orban had used to fix the budget after he swept to power in 2010.
Orban needs to rein in the deficit and avoid recession in the economy, with inflation expected to accelerate to 26-27% in coming months.
The decree said the new tax will be 1% on net revenues below 50 billion forints, and 3% on the part of revenues between 50 billion and 150 billion, jumping to 8% on net revenues exceeding 150 billion forints. Hungary's largest pharma company Richter will be especially hard hit by the new tax.
($1 = 376.5400 forints)
Our Standards: The Thomson Reuters Trust Principles.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。